October 28, 2025
Arovella Therapeutics (ASX:ALA) showcases progress in next-generation iNKT cell therapy at AusBiotech Invest 2025
Arovella Therapeutics (ASX:ALA) has presented its progress toward clinical trials for its lead iNKT cell therapy ALA-101, showcasing its next-generation cancer treatment platform at AusBiotech Invest 2025.